Abstract
Objetive: to present the evidence published about the usefulness of lacosamide in pediatric patients with refractory epilepsy, in order to explain its use in this population.
Methods: we conducted search in PubMed, Embase, Cochrane library and Scielo and found 18 articles that fulfilled the inclusion criteria.
Findings: lacosamide, is one of the newer AED (Antiepileptic Drugs) approved for focal refractory and focal onset epilepsies as an add on treatment in patients older than 16 years. However there is growing evidence of its use, security and efficacy in pediatric population from 4 years and above. Adverse effects do not differ from others found in others AED with success seizure free rates between 8 and 40%. Studies revisited had major issues on long term following. In addition, lacosamide improves behavioral and motor skills in children despite seizure control.
Conclusions: Studies shows lacosamide as a safe option in pediatric patients with focal onset and refractory epilepsies as an add on therapy given its seizure control, safety profile, low rate of adverse effects and interaction between others medications, however larger and long term studies are needed.
References
CHU-SHORE CJ, THIELE EA. New Drugs for Pediatric Epilepsy. Semin Pediatr Neurol [Internet]. Elsevier Inc. 2010;17(4):214-23. http://dx.doi.org/10.1016/j.spen.2010.10.003.
ANEJA S, SHARMA S. Newer Anti-epileptic Drugs. Indian Pediatr. 2013;50:1033-40.
STEPHEN LJ, BRODIE MJ. Pharmacotherapy of Epilepsy Newly Approved and Developmental Agents. CNS 2011;25(2):89-107.
VISHWANATH VA, MCCOY L, LII M. What is the right dose of lacosamide in pediatric patients with intractable epilepsy? Epilepsy Behav [Internet]. Elsevier Inc. 2012;23(3):396-7. http://dx.doi.org/10.1016/j.yebeh.2012.01.014.
BUCK ML, GOODKIN HP, SERVICES P. Use of Lacosamide in Children with Refractory Epilepsy. J Pediatr Pharmacol Ther. 2012;17(3):211-9.
VERROTTI A, LOIACONO G, PIZZOLORUSSO A, PARISI P, BRUNI O, LUCHETTI A, ET AL. Lacosamide in pediatric and adult patients?: Comparison of efficacy and safety. Seizure Eur J Epilepsy [Internet]. BEA Trading Ltd. 2013;22(3):210-6. http://dx.doi.org/10.1016/j.seizure.2012.12.009.
YORNS JR WR, KHURANA DS, CARVALHO KS, HARDISON HH, VALENCIA I. Efficacy of Lacosamide as Adjunctive Therapy in Children With Refractory Epilepsy. J Child Neurol. 2015;29(1):23-7.
RUFO-CAMPOS M, MARTI A, CASAS-FERNA C, SMEYERS-DURA P, CAMPOS-CASTELLO J. Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy. Drugs R D. 2012;12(4):187-97.
PASHA I, PHARM M, KAMATE M, DIDAGI SK. Efficacy and Tolerability of Lacosamide as an Adjunctive Therapy in Children With Refractory Partial Epilepsy. Pediatr Neurol [Internet]. Elsevier Inc. 2014;51(4):509-14. http://dx.doi.org/10.1016/j.pediatrneurol.2014.07.004.
GROSSO S, PARISI P, SPALICE A, VERROTTI A, BALESTRI P. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy. Eur J Paediatr Neurol [Internet]. Elsevier Ltd. 2013;18(1):55-9. http://dx.doi.org/10.1016/j.ejpn.2013.08.006.
GUILHOTO LMFF, LODDENKEMPER T, GOOTY VD, ROTENBERG A, TAKEOKA M, DUFFY FH, ET AL. Experience With Lacosamide in a Series of Children With Drug-Resistant Focal Epilepsy. Pediatr Neurol [Internet]. Elsevier Inc. 2011;44(6):414-9. http://dx.doi.org/10.1016/j.pediatrneurol.2010.12.003.
SOO J, KIM H, CHAN B, CHAE J, CHOI J, JOONG K, ET AL. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy. Brain Dev [Internet]. The Japanese Society of Child Neurology 2014;36(6):510-5. http://dx.doi.org/10.1016/j.braindev.2013.07.003.
HEYMAN E, LAHAT E, LEVIN N, BERKOVITCH M, GANDELMAN-MARTON R. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy. Eur J Paediatr Neurol [Internet]. Elsevier Ltd. 2011;16(1):15-9. http://dx.doi.org/10.1016/j.ejpn.2011.08.007.
GROSSO S, PARISI P, GIORDANO L, BALESTRI P. Lacosamide efficacy in epileptic syndromes with continuous spike and waves during slow sleep (CSWS). Epilepsy Res [Internet]. Elsevier B.V. 2014;108(9):1604-8. http://dx.doi.org/10.1016/j.eplepsyres.2014.08.021.
RASTOGI RG, NG Y. Lacosamide in Refractory Mixed Pediatric Epilepsy?: A Prospective Add-on Study. J Child Neurol. 2015;27(4):492-5.
GAVATHA M, IOANNOU I, PAPAVASILIOU, S. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy. Epilepsy Behav [Internet]. Elsevier Inc. 2011 Abril [citado 2015 Enero 16];20(4):691-3. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21406334.
PASHA I, KAMATE M, SURESH D. Effect of Lacosamide on Behaviour of Children with Refractory partial Epilepsy. Int J Pharm Pharm Sci. 2014;6(11):119-22.
GROSSO S, COPPOLA G, CUSMAI R, PARISI P, SPALICE A, FOLIGNO S. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome. Acta Neurol Scand. 2014;129(3):420-4.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.